ConvaTec Group company profile

CTEC · LSE · GBp

Compare ConvaTec Group
246.80 GBpChange from previous close: −2.37%Absolute change: −6.00 GBp

Close · November 17, 2026

Company profile

ConvaTec Group has 10,000 employees and is headquartered in London, United Kingdom.

With 10,000 employees, ConvaTec Group Plc develops, manufactures and sells medical products and technologies for managing chronic conditions, mainly in Europe, North America and other international markets. Its wound care range covers chronic wounds linked to diabetes as well as acute wounds from trauma and burns, while its ostomy solutions serve people with a stoma after colorectal or bladder cancer, inflammatory bowel disease or injury. Continence products address urinary problems caused by spinal cord injuries, neurological disease or prostate enlargement, and infusion sets are supplied for insulin pumps and continuous treatments such as those for Parkinson's disease. Sales go to pharmacies, hospitals and acute and post-acute care providers, directly or through distributors and wholesalers.

In the fiscal year ended December 2025, revenue reached USD 2.4 billion, up 6.6% on the previous year, and net profit was USD 175 million. Dating from 1978, the group is based in London.

Company facts

Industry
Medical Instruments & Supplies
Headquarters
20 Eastbourne Terrace, W2 6LG, London
Employees
10,000
Chief executive
Jonathan Mason
Founded
1978
Fiscal year
January - December
Listing
CTEC · LSE
Indices
FTSE 100
Currency
GBp
ISIN
GB00BD3VFW73

ConvaTec Group and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
ConvaTec GroupCTECUnited Kingdom$6.51B10,00016.3%51.6
Ypsomed HoldingYPSNSwitzerland$6.76B2,02536.2%34.3
Fielmann GroupFIEGermany$4.05B18,21313.7%16.9
SCHOTT Pharma1SXPGermany$3.69B5,00216.4%24.8
Tecan GroupTECNSwitzerland$3.65B3,0004.9%—
Carl Zeiss MeditecAFXGermany$3.37B5,7847.2%25.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare ConvaTec Group with its competitors